Cyclopharm Ltd
ASX:CYC
Prices of ASX stocks are not being updated. The latest CYC price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cyclopharm Ltd
ASX:CYC
|
AU |
|
R
|
Royal Caribbean Cruises Ltd
F:RC8
|
US |
|
A
|
ADTechnology Co Ltd
KOSDAQ:200710
|
KR |
|
S
|
Samil Enterprise Co Ltd
KOSDAQ:002290
|
KR |
|
P
|
Puma SE
XMUN:PUM
|
DE |
|
E
|
Empire Company Ltd
F:C15
|
CA |
|
Bitcoin Group SE
F:ADE
|
DE |
|
Yatra Online Inc
NASDAQ:YTRA
|
IN |
|
H
|
Heartland Group Holdings Ltd
F:73X
|
NZ |
|
Tata Consultancy Services Ltd
NSE:TCS
|
IN |
Intrinsic Value
Is CYC undervalued or overvalued?
See the intrinsic value estimate for Cyclopharm Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Cyclopharm Does
Cyclopharm Ltd is a medical technology company best known for Technegas, a lung-imaging product used with nuclear medicine scans. It makes and sells equipment and related consumables that help doctors see how air moves through the lungs, which is useful for checking suspected blood clots, COPD, asthma, and other breathing problems. The company also supports hospitals and imaging centers with service, training, and product maintenance.
- Headquarters
- Australia AU
- Employees
- 109
- IPO date
- Jan 18, 2007
Earnings Waterfall
Cyclopharm Ltd
The intrinsic value for Cyclopharm Ltd (CYC) under the Base Case is hidden AUD.
Compared with the last price of 0.455 AUD on Oct 14, the stock appears hidden.